COL1A2 and Miyoshi myopathy: Koga et al reported that more advanced tumors had higher methylation rates for COL1A2 and DDIT4L. 20In the present study, we showed DDIT4L as one of the high‐methylation marker genes that were specifically hypermethylated in high‐methylation MM subgroup exhibiting the progressive tumor phenotype.